TrumpRx delayed as senators question if it's a giant scam with Big Pharma
5 days ago
- #prescription drugs
- #TrumpRx
- #healthcare policy
- The Trump administration delays the release of TrumpRx, an online platform for discounted prescription drugs.
- Democratic senators raise concerns about the legality and oversight of TrumpRx.
- Sens. Durbin, Warren, and Welch seek clarification on how the anti-kickback statute will apply to TrumpRx.
- Senators express concerns about inappropriate prescribing, conflicts of interest, and inadequate care with DTC platforms.
- Details on TrumpRx's operation remain undisclosed, and HHS has not responded to oversight requests.
- Investigations reveal DTC platforms may allow pre-selection of drugs and brief telehealth consultations with potential conflicts of interest.